Early effects predict trajectories of response to esketamine in treatment-resistant depression

I Estrade, AC Petit, V Sylvestre, M Danon… - Journal of Affective …, 2023 - Elsevier
Background The efficacy of esketamine in treatment-resistant depression (TRD) has been
confirmed. However, its administration is expensive and restrictive, with limited knowledge …
被引用次数：4 相关文章

Early effects predict trajectories of response to esketamine in treatment-resistant depression

I Estrade, AC Petit, V Sylvestre, M Danon… - Journal of affective … - pubmed.ncbi.nlm.nih.gov
Background The efficacy of esketamine in treatment-resistant depression (TRD) has been
confirmed. However, its administration is expensive and restrictive, with limited knowledge …
[PDF] ghu-paris.fr

[PDF][PDF] Early effects predict trajectories of response to esketamine in treatment-resistant depression

I Estrade, AC Petit, V Sylvestre, M Danon… - Journal of Affective …, 2023 - ghu-paris.fr
Background: The efficacy of esketamine in treatment-resistant depression (TRD) has been
confirmed. However, its administration is expensive and restrictive, with limited knowledge …

Early effects predict trajectories of response to esketamine in treatment-resistant depression.

I Estrade, AC Petit, V Sylvestre, M Danon… - Journal of Affective …, 2023 - europepmc.org
The efficacy of esketamine in treatment-resistant depression (TRD) has been confirmed.
However, its administration is expensive and restrictive, with limited knowledge on how long …

Early effects predict trajectories of response to esketamine in treatment-resistant depression.

I Estrade, AC Petit, V Sylvestre, M Danon… - Journal of Affective …, 2023 - psycnet.apa.org
Background: The efficacy of esketamine in treatment-resistant depression (TRD) has been
confirmed. However, its administration is expensive and restrictive, with limited knowledge …